Drug application
ORINASE DIAGNOSTIC (TOLBUTAMIDE SODIUM)
Drugs@FDA NDA 012095 · PHARMACIA AND UPJOHN
Key facts
| Drug name | ORINASE DIAGNOSTIC |
|---|---|
| Active ingredients | TOLBUTAMIDE SODIUM |
| Application type | NDA |
| Application number | 012095 |
| Company | PHARMACIA AND UPJOHN |
| Dosage forms | INJECTABLE, INJECTION |
| Strength | EQ 1GM BASE/VIAL |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission class | Type 2 - New Active Ingredient |
| Latest submission status date | Jun 22, 1961 |
At a glance
- 1–9 Submissions
- 1–9 Supplements
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.